Dorte Vistisen
Steno Diabetes Center
157 Papers
399 Citations
Dorte Vistisen is an academic researcher from Steno Diabetes Center. The author has contributed to research in topics: Diabetes mellitus & Medicine. The author has an hindex of 30, co-authored 120 publications. Previous affiliations of Dorte Vistisen include Novo Nordisk & University of Southern Denmark.
Chat about Author
Papers
A cross‐sectional study of glycaemic control, complications and psychosocial functioning among 18‐ to 35‐year‐old adults with Type 1 diabetes
TL;DR: The level of glycaemic control, complications and psychosocial functioning and the relationships between these variables in the under‐researched group of younger adults with Type 1 diabetes are described.
Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study
Kristine Færch,Daniel R. Witte,Adam G. Tabak,Adam G. Tabak,Leigh Perreault,Christian Herder,Eric J. Brunner,Mika Kivimäki,Dorte Vistisen +8 more
TL;DR: Patients with type 2 diabetes diagnosed on the basis of increased fasting glucose concentrations or 2 h glucose concentrations, or both, have distinct cardiometabolic risk development before diagnosis.
Protocol for a single-centre, parallel-group, randomised, controlled, superiority trial on the effects of time-restricted eating on body weight, behaviour and metabolism in individuals at high risk of type 2 diabetes: the REStricted Eating Time (RESET) study.
Jonas Salling Quist,Marie M. Jensen,Kim K. B. Clemmensen,Hanne Pedersen,Natasja Bjerre,Joachim Størling,Joachim Størling,Martin B. Blond,Nicolai J. Wewer Albrechtsen,Jens J. Holst,Signe S. Torekov,Dorte Vistisen,Marit E. Jørgensen,Marit E. Jørgensen,Satchidananda Panda,Christina Brock,Graham Finlayson,Kristine Færch,Kristine Færch +18 more
TL;DR: Results from the study will address whether TRE is effective and feasible in improving health outcomes in individuals at risk of lifestyle-related diseases and can potentially inform the design of feasible health recommendations.
Role of fasting duration and weekday in incretin and glucose regulation
Kim K. B. Clemmensen,Jonas Salling Quist,Dorte Vistisen,Daniel R. Witte,Anna Jonsson,Oluf Pedersen,Torben Hansen,Jens Juul Holst,Torsten Lauritzen,Marit E. Jørgensen,Signe S. Torekov,Kristine Færch +11 more
TL;DR: Higher fasting insulin levels on Mondays compared to the other days of the week, potentially indicating a worsened glucose regulation after the weekend.
Greater glucagon-like peptide-1 responses to oral glucose are associated with lower central and peripheral blood pressures
Julie R. Lundgren,Kristine Færch,Daniel R. Witte,Anna Jonsson,Oluf Pedersen,Torben Hansen,Torsten Lauritzen,Jens J. Holst,Dorte Vistisen,Marit E. Jørgensen,Signe S. Torekov,Nanna B. Johansen +11 more
TL;DR: Greater glucose-stimulated GLP-1 responses were associated with clinically relevant lower central and peripheral blood pressures, consistent with beneficial effects on the cardiovascular system and reduced risk of CVD and mortality.